Yong Wang

11.7k total citations · 3 hit papers
246 papers, 8.6k citations indexed

About

Yong Wang is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Yong Wang has authored 246 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Molecular Biology, 52 papers in Immunology and 52 papers in Biomedical Engineering. Recurrent topics in Yong Wang's work include Nanoplatforms for cancer theranostics (40 papers), Nanoparticle-Based Drug Delivery (37 papers) and RNA Interference and Gene Delivery (36 papers). Yong Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (40 papers), Nanoparticle-Based Drug Delivery (37 papers) and RNA Interference and Gene Delivery (36 papers). Yong Wang collaborates with scholars based in China, United States and Japan. Yong Wang's co-authors include Xintao Shuai, Robert R. Rando, Hong Xiao, Du Cheng, Yongcheng An, Daohong Zhou, Zecong Xiao, Shisong Han, Jingguo Li and Bo Li and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Yong Wang

233 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis

2011 473 citations Yong Wang et al. profile →
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study

2021 251 citations Yong Wang et al. profile →
Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy

2021 182 citations Zecong Xiao, Yongcheng An et al. profile →

Peers

Countries citing papers authored by Yong Wang

Since Specialization

Citations

This map shows the geographic impact of Yong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Wang more than expected).

Fields of papers citing papers by Yong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Wang. The network helps show where Yong Wang may publish in the future.

Co-authorship network of co-authors of Yong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Wang. A scholar is included among the top collaborators of Yong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Wang. Yong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel method for transient analysis of heat pipe cooled reactor based on reduced order model 2025 ·Applied Thermal Engineering ·Yong Wang, (unknown)	5
2	High Trop-2 expression in pulmonary sarcomatoid carcinoma reveals antibody–drug conjugate targeting Trop-2 is a promising therapeutic approach 2025 ·Journal of Translational Medicine ·(unknown), Chuanhong Luo, Fang Chen, Yongbin Wu, (unknown), (unknown), (unknown), Yan Yin, (unknown), Xin Ye, (unknown), (unknown), (unknown), Zhaoqing Li, Shanshan Wang, Yong Wang, (unknown)	0
3	Nonlinear Association Between the Visceral‐to‐Subcutaneous Fat Area Ratio and the Risk of Hypertension in Prediabetic Individuals: Evidence From a Large‐Scale Health Screening Dataset in China 2025 ·Journal of Clinical Hypertension ·(unknown), (unknown), Yongbing Sun, Jing Zhou, (unknown), (unknown), (unknown), Hao Li, (unknown), (unknown), Yong Wang, (unknown), Yongli Li	0
4	Steady state neutronic and thermal–mechanical coupling analysis of inelastic deformation in solid-state heat pipe cooled reactor 2024 ·Annals of Nuclear Energy ·Yong Wang, (unknown), (unknown)	3
5	A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy 2024 ·Journal of Colloid and Interface Science ·(unknown), (unknown), (unknown), Wei Deng, (unknown), Tao Huang, (unknown), Yong Wang	8
6	Twins‐like nanodrugs synchronously transport in blood and coalesce inside tumors for sensitive ultrasound imaging and triggerable penetrative drug delivery 2024 ·SHILAP Revista de lepidopterología ·Yujun Cai, Gengjia Chen, Minzhao Lin, Bo Li, Huihai Zhong, Tan Li, Zecong Xiao, Yong Wang, Xintao Shuai	14
7	Discovery of 3-(1H-benzo[d]imidazole-2-yl)-1H-pyrazol-4 -amine derivatives as novel and potent syk inhibitors for the treatment of hematological malignancies 2023 ·European Journal of Medicinal Chemistry ·Bingbing Cui, Yong Wang, (unknown), Fan Lü, Yu Jiao, Hongmei Li, Jie Feng, Weifang Tang, Tao Lu, Yadong Chen	7
8	Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma 2023 ·Acta Biomaterialia ·Hong Xiao, Xiaoxia Li, Bo Li, Yin Zhong, (unknown), Yong Wang, Shisong Han, Jie Ren, Xintao Shuai	31
9	Gene liposome nanocomplex-loaded dermal substitute promotes diabetic chronic wound healing and angiogenesis in rat 2023 ·Biomedicine & Pharmacotherapy ·Yong Wang, (unknown), Kai Guo, Tao Zhang, (unknown), Z. Zhuang, (unknown), Xiaoying Lin, (unknown), Jian Chen, Wei‐Qiang Tan	11
10	T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma 2023 ·Journal for ImmunoTherapy of Cancer ·Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, Zecong Xiao, Jianxin Liu, Shaohui Deng, (unknown), Wensou Huang, Mingyue Cai, Yongjian Guo, Jingjun Huang, Yong Wang, Liteng Lin, Kangshun Zhu	17
11	Rational design of a meso phosphate-substituted pyronin as a type I photosensitizer for photodynamic therapy 2022 ·Chemical Communications ·Yong Wang, (unknown), Yukun Zhang, (unknown), Xin Zhou	9
12	Nanomedicine Directs Neuronal Differentiation of Neural Stem Cells via Silencing Long Noncoding RNA for Stroke Therapy 2021 ·Nano Letters ·(unknown), Liejing Lu, Yong Wang, (unknown), Zhe Wang, Guanxun Cheng, Xiaohui Duan, Fang Zhang, Mingwei Xie, Hongbo Le, Xintao Shuai, Jun Shen	54
13	Comparing the efficacy and safety of long and short acting drugs targeting Granulocyte Colony-stimulating Factor in cancer patients after chemotherapy: A systematic review and meta-analysis of randomized controlled trials 2020 ·Xinwei Zhang, Yong Wang, Fen Liu, Lin Chen, Lihong Peng, Xiaotong Qiu, Fang Chen, Xiaoyin Qian, (unknown)	0
14	Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors 2020 ·Cancer Immunology Immunotherapy ·Lihong Peng, Yong Wang, Fen Liu, Xiaotong Qiu, Xinwei Zhang, Fang Chen, Xiaoyin Qian, (unknown)	173
15	A reduction and pH dual-sensitive nanodrug for targeted theranostics in hepatocellular carcinoma 2020 ·Biomaterials Science ·Mingyue Cai, Bo Li, Liteng Lin, Jingjun Huang, Yongcheng An, Wensou Huang, (unknown), Yong Wang, Xintao Shuai, Kangshun Zhu	31
16	Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells 2018 ·Molecular Carcinogenesis ·Hai Li, Shikuo Rong, Chao Chen, (unknown), Tuo Chen, Yong Wang, Dongmei Chen, Chun Yang, Jiali Yang	17
17	CCL17‐CCR4 axis promotes metastasis via ERK/MMP13 pathway in bladder cancer 2018 ·Journal of Cellular Biochemistry ·(unknown), (unknown), (unknown), Rui Wang, Yan Li, Shouzhen Chen, Yangyang Xia, Wenfu Wang, Yong Wang, (unknown), Lei Liu, Jianfeng Cui, Shuai Wang, Qinggang Liu, Zonglong Wu, Hu Guo, Benkang Shi	21
18	Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles 2011 ·Molecular BioSystems ·Ashlynn L. Z. Lee, (unknown), Yong Wang, Shazib Pervaiz, Weimin Fan, Yi Yan Yang	35
19	Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation 2010 ·Blood ·Yusuke Shono, Satoshi Ueha, Yong Wang, Jun Abe, Makoto Kurachi, Yoshihiro Matsuno, Tatsuki Sugiyama, Takashi Nagasawa, Masahiro Imamura, Kouji Matsushima	130
20	Toxic Effects of Butachlor on Myocardium of Bufo bufo gargarizans 2009 ·Journal of environmental health ·(unknown), (unknown), Yong Wang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact